“$39 billion market cap will require sales proje
Post# of 144911
![Avatar](/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
This is actually false. BP’s market caps are determined by a price/earnings ratio and that ratio is not 1, as you implied above (a $39 billion market cap would require $39 billion in sales).
Example: Johnson and Johnson has a current market cap of $353.73 billion. Their sales for fiscal year 2019 totaled $80+ billion. Their P/E ratio, without getting into sales vs profit, etc., is 23.82.
So, CYDY would not need annual sales of $39 billion to have a $39 billion dollar market cap. I’d say sales of $10-15 billion per year could result in a $35 billion dollar market cap, but probably higher if leronlimab is being sold for HIV (pending approval), cancer (still in trials), and other indications.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)